Literature DB >> 7693514

Interleukin 1 and tumour necrosis factor activate the mitogen-activated protein (MAP) kinase kinase in cultured cells.

J Saklatvala1, L M Rawlinson, C J Marshall, M Kracht.   

Abstract

Interleukin 1 (IL1) activated mitogen-activated protein (MAP) kinase kinase in human gingival and foreskin fibroblasts and KB cells. Maximal activity was found in cytosolic extracts made after stimulating cells for 15 min. On anion-exchange chromatography two differently charged forms of MAP kinase kinase were identified, both phosphorylated a kinase-defective mutant MAP kinase, and activated recombinant wild type MAP kinase to phosphorylate MBP. Both were inhibited by an antiserum to recombinant MAP kinase kinase and the less acidic form was identified on Western blotting as an antigen of approximately 43 kDa. Indistinguishable forms were very much more strongly induced by phorbol myristate acetate (PMA). TNF had a similar effect to that of IL1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693514     DOI: 10.1016/0014-5793(93)81709-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model.

Authors:  D E Hu; C R Hiley; T P Fan
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

2.  Interleukin 1-induced phosphorylation of MAD3, the major inhibitor of nuclear factor kappa B of HeLa cells. Interference in signalling by the proteinase inhibitors 3,4-dichloroisocoumarin and tosylphenylalanyl chloromethylketone.

Authors:  F Guesdon; T Ikebe; E Stylianou; J Warwick-Davies; S Haskill; J Saklatvala
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

3.  Interleukin-1 activates a novel protein kinase that phosphorylates the epidermal-growth-factor receptor peptide T669.

Authors:  M Kracht; M Shiroo; C J Marshall; J J Hsuan; J Saklatvala
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

4.  Specific activation of beta-casein kinase by the inflammatory cytokines interleukin 1 and tumour necrosis factor.

Authors:  F Guesdon; R J Waller; J Saklatvala
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

5.  Protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat.

Authors:  D E Hu; T P Fan
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

6.  The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndrome.

Authors:  Margherita Sisto; Sabrina Lisi; Massimo D'Amore; Dario Domenico Lofrumento
Journal:  Clin Exp Med       Date:  2014-03-25       Impact factor: 3.984

7.  The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulin-like growth factor-1 in KB cells.

Authors:  G W Gould; A Cuenda; F J Thomson; P Cohen
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

8.  Radiation-induced c-Jun activation depends on MEK1-ERK1/2 signaling pathway in microglial cells.

Authors:  Zhiyong Deng; Guangchao Sui; Paulo Mottin Rosa; Weiling Zhao
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

9.  Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function.

Authors:  F Re; M Sironi; M Muzio; C Matteucci; M Introna; S Orlando; G Penton-Rol; S K Dower; J E Sims; F Colotta; A Mantovani
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic background.

Authors:  Kelsey J Weigel; Laura Rues; Edward J Doyle; Cassandra L Buchheit; John G Wood; Ryan J Gallagher; Laura E Kelly; Jeffrey D Radel; Kenneth A Bradley; Steven M LeVine
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.